Finance

Lists
PGEN:NASDAQ
Precigen Inc
$ 7.66
-1.98%
(-0.15) 1D
10-р сарын 12, 15:40:14 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PGEN...
Open
$ 7.77
High
$ 7.87
Low
$ 7.65
Mkt. cap
2.74 тэрбум
Avg. vol.
4.75 сая
Volume
1.47 сая
52-wk high
$ 8.98
52-wk low
$ 3.04
EPS
-$ 1.10
Beta
0.92
Shares outstanding
358.04 сая
No. of employees
160
Open
$ 7.77
High
$ 7.87
Low
$ 7.65
Mkt. cap
2.74 тэрбум
Avg. vol.
4.75 сая
Volume
1.47 сая
52-wk high
$ 8.98
52-wk low
$ 3.04
EPS
-$ 1.10
Beta
0.92
Shares outstanding
358.04 сая
No. of employees
160
News stories
From web sources and news partners
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
Founded1998 оны 5-р сарын 21
Headquarters-
Sector-
Analyst ratings
Based on 2 analysts giving stock ratings to PGEN in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PGEN in the last 3 months.
Highest
Current $ 7.66
$ 18.00 (+135.14%)
Average
$ 15.00 (+95.95%)
Lowest
$ 12.00 (+56.76%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
$ 18.00
+135.1%
10/01/2026
Yuan Zhi
B. Riley Securities
Buy
Initiated
$ 12.00
+56.8%
09/25/2026
Jason Butler
Citizens JMP
Buy
Maintained
$ 11.00
+43.7%
05/14/2026
Last report
2026 оны 8-р сарын 4
Fiscal period
Q2 2026
- /
Revenue / Est. (USD)
54.98 сая / 27.83 сая
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
2.92 сая
4.56 сая
23.25 сая
54.98 сая
Cost of goods sold
13.41 сая
8.59 сая
8.20 сая
10.09 сая
Cost of revenue
13.41 сая
8.59 сая
8.20 сая
10.09 сая
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.99 сая
17.64 сая
21.05 сая
22.25 сая
Operating expense
23.99 сая
17.64 сая
21.05 сая
22.25 сая
Total operating expenses
37.40 сая
26.23 сая
29.25 сая
32.34 сая
Operating income
-34.48 сая
-21.67 сая
-5.99 сая
22.64 сая
Other non operating income
-111.50 сая
60.00 мян
290.00 мян
16.00 мян
EBT including unusual items
-146.34 сая
-23.50 сая
-7.93 сая
20.07 сая
EBT excluding unusual items
-146.34 сая
-23.50 сая
-7.93 сая
20.07 сая
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-146.34 сая
-23.50 сая
-7.93 сая
20.07 сая
Net profit margin
-5,008.35%
-514.85%
-34.10%
36.51%
Earnings per share
-
-
-
-
Interest and investment income
534.00 мян
1.07 сая
683.00 мян
366.00 мян
Interest expense
-902.00 мян
-2.96 сая
-2.91 сая
-2.95 сая
Net interest expenses
-368.00 мян
-1.90 сая
-2.22 сая
-2.59 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-33.68 сая
-20.53 сая
-4.90 сая
23.74 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс